InsiderClue
Insiders · Profile

MUELLER PETER

Director at BioXcel Therapeutics · EVP, Global R&D, CSO at Vertex Pharmaceuticals. Filing since 16 Nov 2006. CIK 0001256126

BTAI BioXcel Therapeutics, Inc. Director · 6 trades VRTX Vertex Pharmaceuticals EVP, Global R&D, CSO · 64 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BTAI BioXcel Therapeutics, Inc.
23 Aug 2019
Director
Bought
1,554
$14.51K
0.9%
BTAI BioXcel Therapeutics, Inc.
22 Aug 2019
Director
Bought
6,646
$58.68K
4.2%
BTAI BioXcel Therapeutics, Inc.
21 Aug 2019
Director
Bought
1,800
$15.16K
1.1%
BTAI BioXcel Therapeutics, Inc.
7 Dec 2018
Director
Bought
7,400
$37.07K
4.9%
BTAI BioXcel Therapeutics, Inc.
6 Dec 2018
Director
Bought
1,395
$6.98K
0.9%
BTAI BioXcel Therapeutics, Inc.
4 Dec 2018
Director
Bought
4,007
$20.54K
2.8%
VRTX Vertex Pharmaceuticals
16 Jun 2014
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$512.35K
5.0%
VRTX Vertex Pharmaceuticals
14 May 2014
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$505.85K
5.0%
VRTX Vertex Pharmaceuticals
15 Apr 2014
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$462.21K
4.5%
VRTX Vertex Pharmaceuticals
17 Mar 2014
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$587.14K
4.5%
VRTX Vertex Pharmaceuticals
18 Feb 2014
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$619.44K
4.5%
VRTX Vertex Pharmaceuticals
15 Jan 2014
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$590.03K
5.0%
VRTX Vertex Pharmaceuticals
16 Dec 2013
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$485.14K
5.0%
VRTX Vertex Pharmaceuticals
12 Dec 2013
EVP, Global R&D, CSO
Sold, plan not stated
2,900
$189.89K
2.0%
VRTX Vertex Pharmaceuticals
15 Nov 2013
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$469.61K
4.9%
VRTX Vertex Pharmaceuticals
15 Oct 2013
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$549.36K
4.9%
VRTX Vertex Pharmaceuticals
16 Sep 2013
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$579.16K
4.9%
VRTX Vertex Pharmaceuticals
15 Aug 2013
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$580.56K
4.9%
VRTX Vertex Pharmaceuticals
15 Jul 2013
EVP, Global R&D, CSO
Sold, plan not stated
7,500
$647.52K
4.9%
VRTX Vertex Pharmaceuticals
2 Jul 2013
EVP, Global R&D, CSO
Sold, plan not stated
122,300
$9.76M
45.9%
VRTX Vertex Pharmaceuticals
15 Oct 2012
EVP, Global R&D, CSO
Sold, plan not stated
6,500
$344.02K
4.7%
VRTX Vertex Pharmaceuticals
17 Sep 2012
EVP, Global R&D, CSO
Sold, plan not stated
6,500
$373.88K
4.7%
VRTX Vertex Pharmaceuticals
15 Aug 2012
EVP, Global R&D, CSO
Sold, plan not stated
6,500
$351.85K
4.7%
VRTX Vertex Pharmaceuticals
16 Jul 2012
EVP, Global R&D, CSO
Sold, plan not stated
6,500
$343.06K
4.7%
VRTX Vertex Pharmaceuticals
15 Jun 2012
EVP, Global R&D, CSO
Sold, plan not stated
6,500
$366.41K
4.7%
VRTX Vertex Pharmaceuticals
15 May 2012
EVP, Global R&D, CSO
Sold, plan not stated
6,500
$417.82K
4.7%
VRTX Vertex Pharmaceuticals
7 May 2012
EVP, Global R&D, CSO
Sold, plan not stated
79,500
$4.22M
34.9%
VRTX Vertex Pharmaceuticals
20 Sep 2011
EVP, Global R&D, CSO
Sold, plan not stated
25,000
$1.31M
15.7%
VRTX Vertex Pharmaceuticals
15 Sep 2011
EVP, Global R&D, CSO
Sold, plan not stated
9,500
$476.85K
6.6%
VRTX Vertex Pharmaceuticals
29 Aug 2011
EVP, Global R&D, CSO
Sold, plan not stated
9,500
$427.60K
6.6%
VRTX Vertex Pharmaceuticals
15 Jul 2011
EVP, Global R&D, CSO
Sold, plan not stated
2,500
$126.70K
1.8%
VRTX Vertex Pharmaceuticals
15 Jun 2011
EVP, Global R&D, CSO
Sold, plan not stated
2,500
$116.70K
1.8%
VRTX Vertex Pharmaceuticals
16 May 2011
EVP, Global R&D, CSO
Sold, plan not stated
2,500
$142.55K
1.8%
VRTX Vertex Pharmaceuticals
25 Apr 2011
EVP, Global R&D, CSO
Sold, plan not stated
12,500
$625.00K
8.5%
VRTX Vertex Pharmaceuticals
15 Apr 2011
EVP, Global R&D, CSO
Sold, plan not stated
2,500
$118.72K
1.8%
VRTX Vertex Pharmaceuticals
11 Apr 2011
EVP, Global R&D, CSO
Sold, plan not stated
40,000
$1.92M
23.0%
VRTX Vertex Pharmaceuticals
15 Nov 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$55.09K
1.3%
VRTX Vertex Pharmaceuticals
15 Oct 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$57.04K
1.3%
VRTX Vertex Pharmaceuticals
15 Sep 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$59.55K
1.3%
VRTX Vertex Pharmaceuticals
16 Aug 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$58.21K
1.3%
VRTX Vertex Pharmaceuticals
15 Jul 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$54.78K
1.3%
VRTX Vertex Pharmaceuticals
15 Jun 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$55.89K
1.3%
VRTX Vertex Pharmaceuticals
17 May 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$59.82K
1.3%
VRTX Vertex Pharmaceuticals
7 May 2010
EVP, Global R&D, CSO
Sold, plan not stated
6,271
$225.57K
5.0%
VRTX Vertex Pharmaceuticals
15 Apr 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$63.38K
1.3%
VRTX Vertex Pharmaceuticals
15 Mar 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$68.93K
1.3%
VRTX Vertex Pharmaceuticals
16 Feb 2010
EVP, Global R&D, CSO
Sold, plan not stated
1,600
$61.68K
1.3%
VRTX Vertex Pharmaceuticals
3 Feb 2010
EVP, Global R&D, CSO
Sold, plan not stated
3,844
$154.03K
3.3%
VRTX Vertex Pharmaceuticals
26 Jan 2010
EVP, Global R&D, CSO
Sold, plan not stated
2,026
$79.80K
1.7%
VRTX Vertex Pharmaceuticals
15 Jan 2010
EVP Global R&D, CSO
Sold, plan not stated
1,600
$64.52K
1.4%
VRTX Vertex Pharmaceuticals
4 Dec 2009
EVP Global R&D, CSO
Sold, plan not stated
1,600
$63.39K
1.4%
VRTX Vertex Pharmaceuticals
15 Jul 2009
EVP Global R&D, CSO
Sold, plan not stated
2,400
$78.91K
2.0%
VRTX Vertex Pharmaceuticals
15 Jun 2009
EVP Global R&D, CSO
Sold, plan not stated
2,400
$74.45K
2.0%
VRTX Vertex Pharmaceuticals
15 May 2009
EVP Global R&D, CSO
Sold, plan not stated
2,400
$68.54K
2.0%
VRTX Vertex Pharmaceuticals
7 May 2009
EVP, Global R&D, CSO
Sold, plan not stated
12,796
$370.32K
9.9%
VRTX Vertex Pharmaceuticals
15 Apr 2009
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$64.75K
1.8%
VRTX Vertex Pharmaceuticals
16 Mar 2009
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$68.25K
2.4%
VRTX Vertex Pharmaceuticals
17 Feb 2009
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$78.91K
2.4%
VRTX Vertex Pharmaceuticals
4 Feb 2009
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
1,118
$37.62K
1.3%
VRTX Vertex Pharmaceuticals
15 Jan 2009
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$71.11K
2.7%
VRTX Vertex Pharmaceuticals
15 Dec 2008
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$61.94K
2.7%
VRTX Vertex Pharmaceuticals
17 Nov 2008
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$65.14K
2.7%
VRTX Vertex Pharmaceuticals
15 Oct 2008
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$64.05K
2.7%
VRTX Vertex Pharmaceuticals
17 Sep 2008
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$67.06K
2.7%
VRTX Vertex Pharmaceuticals
15 Jul 2008
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
2,400
$77.76K
2.7%
VRTX Vertex Pharmaceuticals
13 May 2008
EVP Drug Innov.& Realiz, CSO
Sold, plan not stated
1,541
$41.79K
1.8%
VRTX Vertex Pharmaceuticals
7 May 2007
CSO&EVP Drug Innov&Realization
Sold, plan not stated
11,401
$348.76K
13.4%
VRTX Vertex Pharmaceuticals
19 Dec 2006
CSO&EVP Drug Innov&Realization
Sold, plan not stated
165
$6.27K
0.3%
VRTX Vertex Pharmaceuticals
20 Nov 2006
CSO&EVP Drug Innov&Realization
Sold, plan not stated
32,314
$1.45M
37.9%
VRTX Vertex Pharmaceuticals
16 Nov 2006
CSO&EVP Drug Innov&Realization
Sold, plan not stated
17,686
$795.87K
17.2%
70 decisions on file.